S
JAZZ icon

Sachetta’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sachetta’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Buy
60
+49
+445% +$10.7K 0.01% 372
2026
Q1 		$2.08K Hold
11
– – ﹤0.01% 889
2025
Q4 		$1.87K Hold
11
– – ﹤0.01% 798
2025
Q3 		$1.45K Hold
11
– – ﹤0.01% 901
2025
Q2 		$1.17K Sell
11
-8
-42% -$869 ﹤0.01% 955
2025
Q1 		$2.36K Hold
19
– – ﹤0.01% 754
2024
Q4 		$2.34K Buy
19
+8
+73% +$943 ﹤0.01% 786
2024
Q3 		$1.23K Hold
11
– – ﹤0.01% 997
2024
Q2 		$1.24K Buy
+11
New +$1.21K ﹤0.01% 991

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Sachetta's JAZZ Position: Q2 2026 in Review

Sachetta increased its Jazz Pharmaceuticals (JAZZ) stake by 445% in Q2 2026, buying an estimated $10.7K and bringing the position to 60 shares worth $14.5K. The position accounts for 0.01% of the portfolio, ranked #372.

Sachetta first reported a position in JAZZ in Q2 2024 and has held it in 9 quarters since. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Sachetta held 60 shares of Jazz Pharmaceuticals worth $14.5K as of Q2 2026.
  • Sachetta bought 49 Jazz Pharmaceuticals shares in Q2 2026, an estimated $10.7K.
  • Jazz Pharmaceuticals made up 0.01% of Sachetta's portfolio in Q2 2026, its #372 holding.
  • Sachetta first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.